Trial
NCT04492722
A Study to Evaluate the Safety and Efficacy of AZD5718 in Participants With Proteinuric Chronic Kidney Disease
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
AstraZeneca
Collaborators
Parexel; Emerald Clinical Inc.
Condition
Chronic Kidney Disease
Intervention
AZD5718
Why stopped
The Sponsor decided to terminate the study early due to lack of efficacy. There were no safety concerns related to the study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-12-20